When I said perhaps they were jerking around with the trials I was talking about the timing of p.r. releases. I wasn't trying to imply they were slowing down the actual trial.
Regardless, I think we are very vulnerable to a downward drift or even worse should the overall market take a turn south. That was the purpose of posing the question on Bio Values. I
IMO, there is no real compelling reason to BUY the stock before the end of the year. A lot of damage could be done in 2-3 months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.